[go: up one dir, main page]

NO984937L - Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling - Google Patents

Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling

Info

Publication number
NO984937L
NO984937L NO984937A NO984937A NO984937L NO 984937 L NO984937 L NO 984937L NO 984937 A NO984937 A NO 984937A NO 984937 A NO984937 A NO 984937A NO 984937 L NO984937 L NO 984937L
Authority
NO
Norway
Prior art keywords
antigen
immunosuppressive therapy
new peptides
peptides suitable
specific immunosuppressive
Prior art date
Application number
NO984937A
Other languages
English (en)
Norwegian (no)
Other versions
NO984937D0 (no
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO984937D0 publication Critical patent/NO984937D0/no
Publication of NO984937L publication Critical patent/NO984937L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO984937A 1996-04-24 1998-10-23 Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling NO984937L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201106 1996-04-24
PCT/EP1997/002051 WO1997040068A1 (en) 1996-04-24 1997-04-22 Novel peptides suitable for use in antigen specific immunosuppressive therapy

Publications (2)

Publication Number Publication Date
NO984937D0 NO984937D0 (no) 1998-10-23
NO984937L true NO984937L (no) 1998-12-01

Family

ID=8223915

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984937A NO984937L (no) 1996-04-24 1998-10-23 Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling

Country Status (20)

Country Link
US (1) US6184204B1 (xx)
EP (1) EP0920451A1 (xx)
JP (1) JP2000510106A (xx)
KR (1) KR20000010561A (xx)
CN (1) CN1216551A (xx)
AR (1) AR006813A1 (xx)
AU (1) AU719481B2 (xx)
BR (1) BR9708744A (xx)
CA (1) CA2251680A1 (xx)
CZ (1) CZ340698A3 (xx)
HU (1) HUP9901375A3 (xx)
IL (1) IL120561A0 (xx)
NO (1) NO984937L (xx)
NZ (1) NZ332427A (xx)
PL (1) PL329618A1 (xx)
RU (1) RU2199548C2 (xx)
TR (1) TR199802135T2 (xx)
TW (1) TW575583B (xx)
WO (1) WO1997040068A1 (xx)
ZA (1) ZA973071B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010071020A (ko) 1998-07-23 2001-07-28 에프.지.엠. 헤르만스 ; 이.에이치. 리링크 자가 면역 질환의 면역 요법에서 사용하기 위한 신규한펩티드
NZ518256A (en) * 1999-10-18 2004-01-30 Akzo Nobel Nv Modified peptides and peptidomimetics for use in immunotherapy
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
PT1309591E (pt) 2000-08-14 2007-04-30 Ortho Mcneil Pharm Inc Pirazoles substituídos
US7002985B2 (en) * 2001-01-16 2006-02-21 Motorola, Inc. Method and apparatus for organizing and scheduling multimedia data transfers over a wireless channel
US7902143B2 (en) * 2004-12-07 2011-03-08 Toray Industries, Inc. Cancer antigen peptide and the use thereof
ATE493439T1 (de) * 2005-02-28 2011-01-15 Bio Y As Monoklonale ykl-40-antikörper
FR2908654B1 (fr) * 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
DK2172211T3 (en) * 2008-10-01 2015-02-16 Immatics Biotechnologies Gmbh Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
RU2008140688A (ru) * 2008-10-15 2010-04-20 Михаил Аркадьевич Шурдов (RU) Иммуносупрессивный пептид
CA2768246A1 (en) 2009-06-11 2010-12-16 The University Of Guelph Serine rich peptides having antioxidative stress properties
US8815806B2 (en) 2009-10-28 2014-08-26 University Of Manitoba Yellow pea seed protein-derived peptides
EP3168226A3 (en) 2010-05-31 2017-07-26 London Health Sciences Centre Research Inc. Rhamm binding peptides
WO2018129261A1 (en) 2017-01-05 2018-07-12 Brown University Methods and compositions relating to anti-chi3l1 antibody reagents
US10766968B2 (en) 2017-08-23 2020-09-08 Brown University Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
US6184204B1 (en) 2001-02-06
TW575583B (en) 2004-02-11
NO984937D0 (no) 1998-10-23
BR9708744A (pt) 1999-08-03
CN1216551A (zh) 1999-05-12
AU2768597A (en) 1997-11-12
RU2199548C2 (ru) 2003-02-27
ZA973071B (en) 1998-08-05
AR006813A1 (es) 1999-09-29
JP2000510106A (ja) 2000-08-08
CA2251680A1 (en) 1997-10-30
NZ332427A (en) 2000-03-27
PL329618A1 (en) 1999-03-29
WO1997040068A1 (en) 1997-10-30
EP0920451A1 (en) 1999-06-09
HUP9901375A3 (en) 2000-10-30
AU719481B2 (en) 2000-05-11
IL120561A0 (en) 1997-07-13
TR199802135T2 (xx) 1999-01-18
KR20000010561A (ko) 2000-02-15
HUP9901375A2 (hu) 1999-08-30
CZ340698A3 (cs) 1999-02-17

Similar Documents

Publication Publication Date Title
DE69717192D1 (de) Von einem Patienten tragbare Energieabgabevorrichtung
DE69601413D1 (de) Brennstoffzuführvorrichtung
DE69709885D1 (de) Speichersystem und einrichtung
DE69820357D1 (de) Verstellbarer Hochstuhl
NO991903D0 (no) Naftyridinderivater
DE19781991T1 (de) Einstellbare Lendenstütze
DE69734951D1 (de) Halbleiteranordnung und Speichersystem
NO984937L (no) Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling
DE69702518D1 (de) Kraftstoffabgabevorrichtung
GB9713399D0 (en) Portable device and concentrator therefor
FI101738B1 (fi) Ruiskutusventtiilijärjestely
DK0770132T3 (da) Nye streptograminer
DE69725663D1 (de) Abrechnungsverfahren und System
DE69636153D1 (de) Tragbarer Speicherträger und Ausgabesystem dafür
DK0931436T3 (da) Energifordelingssystem
IT1282692B1 (it) Citochine modificate per l'uso in terapia
IT1285669B1 (it) Elettrocatetere, in particolare per uso temporaneo
NO982077L (no) Energifordelingssystem i skip
KR970060499U (ko) 미용의자 높낮이 조절장치
KR970056712U (ko) 조정식 미용 의자
EA199900378A1 (ru) Устройство для распределения воды в градирне
FR2746557B3 (fr) Generateur solaire portable
DE59710845D1 (de) Schwenkbare Trageinrichtung
SE9602287D0 (sv) Novel protein and methods for its use
SE9602645D0 (sv) Azabicyclic derivatives useful in therapy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application